IDEX Corporation Completes Acquisition of Iridian Spectral Technologies
22 Mai 2023 - 12:16PM
Business Wire
IDEX Corporation (NYSE:IEX) today announced that it has
completed its previously-announced acquisition of Iridian Spectral
Technologies (“Iridian”), a global leader in designing and
manufacturing thin-film, multi-layer optical filters.
Based in Ottawa, Ontario, Canada, Iridian has proven expertise
in optical filter design and production, serving the laser
communications, telecommunications, and life sciences markets.
Iridian provides support throughout a product’s lifecycle, from
initial prototyping to high-volume manufacturing. It offers
advanced, proprietary thin-film design deposition and manufacturing
technology of durable, high-performance filter optics.
“The addition of Iridian expands our already strong array of
optical technology offerings and aligns with our company’s
strategic growth plans,” IDEX Chief Executive Officer and President
Eric Ashleman said. “We welcome the Iridian team to IDEX, where
they will increase our offerings in core markets we serve now and
allow us to expand into new ones.”
Iridian joins IDEX Optical Technologies (CVI Laser Optics, CVI
Infrared Optics, and Advanced Thin Films) within Scientific
Fluidics & Optics in IDEX’s Health & Science Technology
segment. Iridian will also be a strong partner in the life science
filters business driven by the Semrock team of IDEX Health &
Science.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking” statements within
the meaning of the Private Securities Litigation Reform Act of
1995, as amended. Such forward-looking statements include
statements regarding the expected benefits of the acquisition of
Iridian, the expected impact of the acquisition on IDEX’s product
offerings or proposed product offerings, the enhancement of IDEX’s
business strategy, and expected growth opportunities. These
statements are subject to inherent uncertainties and risks that
could cause actual results to differ materially from those
anticipated at the date of this press release. The risks and
uncertainties include, but are not limited to, the following:
levels of industrial activity and economic conditions in the U.S.
and other countries around the world, including uncertainties in
the financial markets and adverse developments affecting the
financial services industry; pricing pressures, including inflation
and rising interest rates, and other competitive factors and levels
of capital spending in certain industries, all of which could have
a material impact on order rates and IDEX’s results; the impact of
health epidemics and pandemics and terrorist attacks and wars,
including the ongoing conflict between Russia and Ukraine, which
could have an adverse impact on IDEX's business by creating
disruptions in the global supply chain and by potentially having an
adverse impact on the global economy; IDEX’s ability to integrate
Iridian and to acquire, integrate and operate other acquired
businesses on a profitable basis; the relationship of the U.S.
dollar to other currencies and its impact on pricing and cost
competitiveness; political and economic conditions in foreign
countries in which IDEX operates; developments with respect to
trade policy and tariffs; interest rates; capacity utilization and
the effect this has on costs; labor markets; supply chain backlogs,
including risks affecting component availability, labor
inefficiencies and freight logistical challenges; market conditions
and material costs; risks related to environmental, social and
corporate governance issues, including those related to climate
change and sustainability; and developments with respect to
contingencies, such as litigation and environmental matters.
Additional factors that could cause actual results to differ
materially from those reflected in the forward-looking statements
include, but are not limited to, the risks discussed in the “Risk
Factors” section included in IDEX’s most recent annual report on
Form 10-K and IDEX’s subsequent quarterly reports filed with the
Securities and Exchange Commission (“SEC”) and the other risks
discussed in IDEX’s filings with the SEC. The forward-looking
statements included here are only made as of the date of this press
release, and management undertakes no obligation to publicly update
them to reflect subsequent events or circumstances, except as may
be required by law. Investors are cautioned not to rely unduly on
forward-looking statements when evaluating the information
presented here.
About IDEX
IDEX Corporation (NYSE: IEX) makes thousands of products and
mission-critical components that improve everyday life all around
you. If you enjoy chocolate, it quite possibly passed through a
Viking® internal gear pump at the candy factory. If you were ever
in a car accident, emergency workers may have used the Hurst Jaws
of Life® rescue tool to save your life. If your doctor ordered a
DNA test to predict your risk of disease or determine a course of
treatment, the lab may have used equipment containing components
made by IDEX Health & Science. Founded in 1988 with three
small, entrepreneurial manufacturing companies, we’re proud to say
that we now call over 50 diverse businesses around the world part
of the IDEX family. With more than 8,500 employees and
manufacturing operations in more than 20 countries, IDEX is a
high-performing, global company with over $3.1 billion in annual
sales, committed to making trusted solutions that improve lives.
IDEX shares are traded on the New York Stock Exchange under the
symbol “IEX”.
For further information on IDEX Corporation and its business
units, visit IDEX’s website at www.idexcorp.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230522005301/en/
Investor Contact IDEX Corporation
Allison Lausas Vice President and Chief Accounting Officer +1
847-498-7070 investorrelations@idexcorp.com
Media Contact: IDEX Corporation
Mark Spencer +1 847-457-3793 mdspencer@idexcorp.com
IDEX (NYSE:IEX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
IDEX (NYSE:IEX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024